
### [MONDO:0003576](http://purl.obolibrary.org/obo/MONDO_0003576)
**Label:** large intestine cancer

**Subclasses:** [MONDO:0007108](http://purl.obolibrary.org/obo/MONDO_0007108) (anal canal carcinoma), [MONDO:0002735](http://purl.obolibrary.org/obo/MONDO_0002735) (anal canal adenocarcinoma (disease)), [MONDO:0005008](http://purl.obolibrary.org/obo/MONDO_0005008) (colorectal adenocarcinoma), 

**Corr. equiv. classes:** [Orphanet:424013](http://www.orpha.net/ORDO/Orphanet_424013), [OMIM:105580](http://purl.obolibrary.org/obo/OMIM_105580), [OMIM:114500](http://purl.obolibrary.org/obo/OMIM_114500), [Orphanet:424016](http://www.orpha.net/ORDO/Orphanet_424016), 

**Class expressions from DL-Learner:**

- [HP:0002891](http://purl.obolibrary.org/obo/HP_0002891) (Uterine leiomyosarcoma) 62.50%
- [HP:0100243](http://purl.obolibrary.org/obo/HP_0100243) (Leiomyosarcoma) and [HP:0100834](http://purl.obolibrary.org/obo/HP_0100834) (Neoplasm of the large intestine) 62.50%
- [HP:0031105](http://purl.obolibrary.org/obo/HP_0031105) (Abnormal uterus morphology) and [HP:0100243](http://purl.obolibrary.org/obo/HP_0100243) (Leiomyosarcoma) 62.50%
- [HP:0010784](http://purl.obolibrary.org/obo/HP_0010784) (Uterine neoplasm) and [HP:0100243](http://purl.obolibrary.org/obo/HP_0100243) (Leiomyosarcoma) 62.50%
- [HP:0010460](http://purl.obolibrary.org/obo/HP_0010460) (Abnormality of the female genitalia) and [HP:0100243](http://purl.obolibrary.org/obo/HP_0100243) (Leiomyosarcoma) 62.50%
- [HP:0009725](http://purl.obolibrary.org/obo/HP_0009725) (Bladder neoplasm) and [HP:0100243](http://purl.obolibrary.org/obo/HP_0100243) (Leiomyosarcoma) 62.50%
- [HP:0006753](http://purl.obolibrary.org/obo/HP_0006753) (Neoplasm of the stomach) and [HP:0100243](http://purl.obolibrary.org/obo/HP_0100243) (Leiomyosarcoma) 62.50%
- [HP:0006749](http://purl.obolibrary.org/obo/HP_0006749) (Malignant gastrointestinal tract tumors) and [HP:0100243](http://purl.obolibrary.org/obo/HP_0100243) (Leiomyosarcoma) 62.50%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and [HP:0100243](http://purl.obolibrary.org/obo/HP_0100243) (Leiomyosarcoma) 62.50%
- [HP:0006716](http://purl.obolibrary.org/obo/HP_0006716) (Hereditary nonpolyposis colorectal carcinoma) and [HP:0100243](http://purl.obolibrary.org/obo/HP_0100243) (Leiomyosarcoma) 62.50%
- [HP:0005584](http://purl.obolibrary.org/obo/HP_0005584) (Renal cell carcinoma) and [HP:0100243](http://purl.obolibrary.org/obo/HP_0100243) (Leiomyosarcoma) 62.50%
- [HP:0002891](http://purl.obolibrary.org/obo/HP_0002891) (Uterine leiomyosarcoma) and [HP:0100834](http://purl.obolibrary.org/obo/HP_0100834) (Neoplasm of the large intestine) 62.50%
- [HP:0002891](http://purl.obolibrary.org/obo/HP_0002891) (Uterine leiomyosarcoma) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 62.50%
- [HP:0002891](http://purl.obolibrary.org/obo/HP_0002891) (Uterine leiomyosarcoma) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 62.50%
- [HP:0002891](http://purl.obolibrary.org/obo/HP_0002891) (Uterine leiomyosarcoma) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) 62.50%


